Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of “Real-world” Evidence

IMPORTANCE: Omalizumab is indicated for the management of chronic idiopathic urticaria (CIU) (also known as chronic spontaneous urticaria) in adolescents and adults with persistent hives not controlled with antihistamines. The effectiveness of omalizumab in the real-world management of CIU is largel...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Dermatol
Hlavní autoři: Tharp, Michael D., Bernstein, Jonathan A., Kavati, Abhishek, Ortiz, Benjamin, MacDonald, Karen, Denhaerynck, Kris, Abraham, Ivo, Lee, Christopher S.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2018
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6439579/
https://ncbi.nlm.nih.gov/pubmed/30427977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2018.3447
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky